VN August 2021
Vetnews | August 2021 15 Article of the inflammatory leukogram. Glucocorticoid treatment was gradually decreased by 25% to 30%every 3 to 4weeks, on condition that clinical signs remained resolved and physical examination was normal. Abdominal ultrasonography was performed 1 month after initial diagnosis, revealing resolution of the mesenteric lymphadenopathy. Prognosis & Outcome Treatment with glucocorticoids was discontinued ≈4 months after diagnosis because the patient remained clinically well. Ruby remained healthy without treatment 2.5 years after initial presentation. Discussion Sterile steroid-responsive lymphadenitis (SSRL) is not well- characterised in dogs; however, it should be considered in dogs with pyrexia of unknown origin and inflammatory lymphadenopathy for which no underlying cause can be found. There is little information available about SSRL. Two retrospective, multicentric studies discussed this condition (including clinical signs, diagnostic approach, and treatment) in different breeds, 3 particularly in English springer spaniels. 4 Other case reports/series have also reported on SSRL, especially in English springer spaniels with or without concurrent dermatologic signs. 5-8 A diagnosis of SSRL can be determined via cytology and/or histopathology by documenting an inflammatory infiltrate in lymph nodes without evidence of infectious agents or other underlying disease. It is key that infectious causes be excluded before SSRL is diagnosed; geographic variations are important considerations in these cases, asprevalenceof infectiousdiseasecanvarydependingon the region or country. Good clinical response is initially seen in most patients after glucocorticoid initiation, but other immunosuppressants can be considered if patient response is suboptimal or steroid adverse effects are severe. Relapses are possible after discontinuation of therapy, so monitoring may be necessary. 3,4 CRP evaluation has been used as a monitoring technique. Young female dogs, particularly English springer spaniels, seem to be predisposed to lymphadenitis. 3,4 Previous reports of lymphadenitis in English springer spaniels included a case of sterile neutrophilic- macrophagic lymphadenitis associated with nodular panniculitis, 6 granulomatous necrotising lymphadenitis, 7 and mineral-associated lymphadenopathy. 8 SSRL should be on the differential diagnosis list for young adult dogs presented with pyrexia and lymphadenopathy. References 1. Thompson MS. Clinical signs approach to differential diagnosis. In : Thompson MS. Small Animal Medical Differential Diagnosis . 2nd ed. St. Louis, MO: Elsevier Saunders; 2014:2-75. 2. Raskin RE. Hemolymphatic system. In : Raskin RE, Meyer DJ, eds. Canine and Feline Cytology: A Color Atlas and Interpretation Guide . 3rd ed. St. Louis, MO: Elsevier; 2016:91-137. 3. Ribas Latre A, McPartland A, Cain D, et al . Canine sterile steroid-responsive lymphadenitis in 49 dogs. J Small Anim Pract . 2019;60(5):280-290. 4. Dor C, Gajanayake I, Kortum A, et al . Characterisation and outcome of idiopathic pyogranulomatous lymphadenitis in 64 English springer spaniel dogs. J Small Anim Pract . 2019;60(9):551-558. 5. Fraga-Manteiga E, Fraga-Veloso G, Schwarz T. Idiopathic sterile pyogranulo¬matous lymphadenitis in a nine-month-old springer spaniel. Vet Rec . 2016;4:e000347. 6. Dandrieux JR, Timm K, Roosje PJ, et al . Unusual systemic signs in a dog with sterile neutrophilic-macrophagic lymphadenitis and nodular panniculitis. J Am Anim Hosp Assoc . 2011;47(2):117-121. 7. Hoffmann I, Genovese L, Whitbread TJ. Granulomatous necrotising lymphadenitis in springer spaniels. Vet Rec . 2002;151(10):308. 8. Day MJ. Expression of interleukin-1β, interleukin-6 and tumour necrosis factor α by macrophages in canine lymph nodes with mineral- associated lymphadenopathy, granulomatous lymphadenitis or reactive hyperplasia. J Comp Path . 1996;114(1):31-42. T REATMENT AT A GLANCE • Glucocorticoid treatment can be started after infectious causes have been excluded. • Most patients seem to respond to glucocorticoid therapy, and rapid resolution of clinical signs is associ- ated with resolution of lymphadenopathy. • Immunosuppressive glucocorticoids are often necessary to control clinical signs. • Other immunosuppressive medications may be needed if patient response is suboptimal or steroid adverse ef- fects are severe. TAKE-HOME MESSAGES • SSRL should be considered in dogs that have pyrexia and variable degrees of lymphadenopathy. • Clinical signs can vary. • Definitive diagnosis of SSRL involves extensive investiga- tion to rule out detectable underlying infectious, inflam- matory, or neoplastic causes. • Lymphadenopathy can be external, internal, or both. • Young female dogs, particularly English springer spaniels, seem to be predisposed. 3,4 • CRP can be used for monitoring purposes. • Relapses are possible. CRP = C-reactive protein, SSRL = Sterile steroid-responsive lymph- adenitis v Content from Around the Globe, FREE. Subscribe to GlobalBrief , the weekly global Clinician’sBrief newsletter. It's FREE for all members of WSAVA associations. GLOBAL CONTENT DELIVERED DIRECTLY TO YOU SUBSCRIBE TODAY AT CLINICIANSBRIEF.COM/GLOBAL
Made with FlippingBook
RkJQdWJsaXNoZXIy OTc5MDU=